Alembic Pharmaceuticals has informed that the 13th Annual General Meeting of the Company was held on 4th August, 2023 through Video Conferencing (VC) / Other Audio Visual Means (OAVM). It enclosed Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Scrutinizers' Report on E-voting as per the provisions of Section 108 of the Companies Act, 2013 read with Companies (Management and Administration), Rules, 2014.
The above information is a part of company’s filings submitted to BSE.
